European Journal of Case Reports in Internal Medicine (May 2015)

Hydroxychloroquine Myocardial Toxicity in a Patient with Systemic Lupus Erythematosus

  • Pierre Malchair,
  • Maria Labori,
  • Manuel Rubio-Rivas,
  • Joel Salazar-Mendiguchia,
  • Nuria Baixeras,
  • Xavier Corbella

DOI
https://doi.org/10.12890/2015_000204
Journal volume & issue
Vol. 2, no. 3

Abstract

Read online

Hydroxychloroquine is an antimalarial drug used in many rheumatologic and systemic diseases. Although considered by clinicians to be relatively safe, serious side effects have been documented (retinotoxicity, neuromyotoxicity and cardiotoxicity). We present the case of a 41-year-old woman with systemic lupus erythematosus (SLE) who presented at our institution with acute heart failure after taking hydroxychloroquine for a period of 3 months. An endomyocardial biopsy ruled out myocarditis related to systemic lupus erythematosus but demonstrated pathological changes related to hydroxychloroquine toxicity. It is exceptional to observe such cardiac toxicity after such a low cumulative dose (16 grams). The potential severity and reversibility of this complication underscores the importance of a high level of suspicion and timely diagnosis.

Keywords